Aphios


Aphios is a green biotechnology company focused on developing enabling nanotechnology platforms and enhanced therapeutics for health maintenance, disease prevention, and treatment of various conditions including cancers, infectious diseases, and central nervous system (CNS) disorders. The company emphasizes environmentally-sustainable practices and aims to improve the quality of life through innovative therapies.

Aphios Logo

Aphios

87 Main Street, North Reading, MA 01864 USA


Patents

Thermal conversion of CBDA and other carboxylic cannabinoids

2024-08-27 • US-12071419-B2

View Details

Bryoid compositions, methods of making and use thereof

2023-05-02 • US-11639359-B2

View Details

Combination HIV therapeutic

2022-02-01 • US-11234932-B2

View Details

Bryoid compositions, methods of making and use thereof

2021-03-23 • US-10954248-B2

View Details

Combination therapeutics and methods for the treatment of neurodegenerative and other diseases

2020-11-10 • US-10828276-B2

View Details

Transplantation therapies

2020-07-28 • US-10723744-B2

View Details

What We Do

Developing enhanced therapeutics for treating cancers, infectious diseases, and CNS disorders, as well as quality-of-life medicines and research chemicals.

An enhanced ginger product for treating chemotherapy-induced nausea and vomiting, recently completed a successful Phase 2/3 clinical trial.

A non-toxic Vitamin D3 analog for hormone-refractory prostate cancer, designed to have increased antiproliferative effects while reducing systemic toxicity.

A Taxotere® prodrug encapsulated in biodegradable polymer nanospheres to enhance oral bioavailability for chronic chemotherapy.

A combination of a Taxotere® prodrug and monoclonal antibody targeted to treat metastatic cancer.

A nanosomal formulation of paclitaxel for treating Kaposi’s sarcoma and skin cancers.


Routes of Administration

Regenerative Medicine

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.